Zanamivir

DrugBank ID: DB00558

Summary

Metric	Value
Total Predictions	50
KG+DL (Dual Validated)	0
DL Only	50
KG Only	0

Predictions

Indication	Score	Source
pyelonephritis	0.9984	DL
influenza, severe, susceptibility to	0.9942	DL
disorder of tyrosine metabolism	0.9902	DL
teratogenic Pierre Robin syndrome	0.9894	DL
disorder of phenylalanine metabolism	0.9886	DL
tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria	0.9841	DL
aspergillosis, susceptibility to	0.9840	DL
dengue virus, susceptibility to	0.9840	DL
legionnaire disease, susceptibility to	0.9840	DL
susceptibility to HIV infection	0.9840	DL
Schistosoma mansoni infection, susceptibility	0.9835	DL
influenza	0.9817	DL
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency	0.9813	DL
staphylococcus aureus infection	0.9791	DL
pyogenic bacterial infections due to MyD88 deficiency	0.9783	DL
acute hemorrhagic encephalitis	0.9778	DL
HHV-6 encephalitis	0.9776	DL
Hendra virus infection	0.9776	DL
acute necrotizing encephalitis	0.9776	DL
equine encephalitis	0.9764	DL
Kaposi sarcoma, susceptibility to	0.9762	DL
hyperamylasemia	0.9751	DL
polyclonal hyperviscosity syndrome	0.9751	DL
Nipah virus disease	0.9716	DL
congenital analbuminemia	0.9676	DL
streptococcal pneumonia	0.9672	DL
blood group incompatibility	0.9651	DL
premalignant hematological system disease	0.9623	DL
monoclonal gammopathy	0.9596	DL
herpes simplex encephalitis	0.9568	DL
hematological disease associated with an acquired peripheral neuropathy	0.9536	DL
congenital hematological disorder	0.9479	DL
pneumonia	0.9363	DL
neonatal epileptic encephalopathy due to glutaminase deficiency	0.9323	DL
genetic otorhinolaryngological malformation	0.9314	DL
idiopathic bilateral vestibulopathy	0.9306	DL
semicircular canal dehiscence syndrome	0.9306	DL
inherited susceptibility to mycobacterial diseases	0.9246	DL
pleural adenomatoid tumor	0.9218	DL
inborn disorder of phenylalanin or tyrosine metabolism	0.9213	DL
pleural biphasic mesothelioma	0.9190	DL
septicemic plague	0.9189	DL
hematopoietic and lymphoid system neoplasm	0.9148	DL
propylthiouracil embryofetopathy	0.9134	DL
lymphohistiocytoid mesothelioma	0.9130	DL
juvenile nasopharyngeal angiofibroma (disease)	0.9124	DL
familial nasal acilia	0.9112	DL
tetrahydrobiopterin metabolic process disease	0.9105	DL
pleural epithelioid mesothelioma	0.9095	DL
silent sinus syndrome	0.9084	DL

External Links

Disclaimer
Predictions are for research purposes only and do not constitute medical advice.